Drug Database
Back to search

Poland· PL-100502121

COMIRNATY JN.1

A covid-19, rna-based vaccine product containing szczepionka mrna przeciw covid-19 (ze zmodyfikowanymi nukleozydami), registered in Poland by BioNTech Manufacturing GmbH. The same ATC class is registered in 11 of our 19 countries.

ATC J07BN01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCOMIRNATY JN.1ATCJ07BN01REGISTER NO.PL-100502121PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about szczepionka mrna przeciw covid-19 (ze zmodyfikowanymi nukleozydami)Answers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Covid-19, rna-based vaccine is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BN01 (covid-19, rna-based vaccine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search covid-19, rna-based vaccine products by name

Covid-19, rna-based vaccine · ATC J07BN01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)
Manufacturer
BioNTech Manufacturing GmbH
Country
Poland (PL)
ATC code
J07BN01
ATC class
Covid-19, RNA-based vaccine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BN01

Covid-19, rna-based vaccine, as other registers publish it.

All covid-19, rna-based vaccine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4bcae85-4dc2-4387-bc94-d530f9a19a06
GET /v1/drugs/c4bcae85-4dc2-4387-bc94-d530f9a19a06?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Koncentrat do sporządzania dyspersji do wstrzykiwań",
  "source": "urpl",
  "strength": "3 mcg (0,3 ml)/dawkę",
  "packaging": "Rp ¦ EU/1/20/1528/035 ¦ 157360\n10 fiol. 0,48 ml (3 dawki/fiol.)",
  "substance": null,
  "common_name": "Szczepionka mRNA przeciw COVID-19 (ze zmodyfikowanymi nukleozydami)",
  "pl_product_id": "100502121",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about covid-19, rna-based vaccine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console